By Thomas Anderson, Rotem Petranker — 2018
We just ran the first ever pre-registered scientific study on the microdosing of psychedelics and found some very promising results.
Read on theconversation.com
CLEAR ALL
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.